Affinity DataIC50: 2.48E+4nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 8.65E+4nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 9.31E+4nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 9.44E+4nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 9.57E+4nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 9.61E+4nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 1.08E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 1.24E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of thrombin-induced platelet aggregation pr...More data for this Ligand-Target Pair
Affinity DataIC50: 4.25E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 4.88E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation preincu...More data for this Ligand-Target Pair
Affinity DataIC50: 5.90E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of U46619-induced platelet aggregation prei...More data for this Ligand-Target Pair
Affinity DataIC50: 6.83E+5nMAssay Description:Antagonist activity at GP2b/3a receptor in New Zealand rabbit platelet-rich plasma assessed as inhibition of collagen-induced platelet aggregation pr...More data for this Ligand-Target Pair
